30.38

0.73% 0.22

After Hours: 30.12 -0.26 -0.86%

Eton Pharmaceuticals Inc (ETON)

Overview News Price History Option Chain Financials Discussions Forecast

Eton Pharmaceuticals Inc stock is traded at $30.38, with a volume of 567.63K. It is up +0.73% in the last 24 hours and up +21.57% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Previous Close:

$30.16

Open:

$30.25

24h Volume:

567.63K

Relative Volume:

1.51

Market Cap:

$831.19M

Revenue:

$79.95M

Net Income/Loss:

$-4.60M

P/E Ratio:

-170.01

EPS:

-0.1787

Net Cash Flow:

$10.19M

1W Performance:

+25.75%

1M Performance:

+21.57%

6M Performance:

+57.82%

1Y Performance:

+79.02%

1-Day Range:

$30.10

$32.31

1-Week Range:

$23.33

$32.31

52-Week Range:

$13.09

$32.31

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name

Eton Pharmaceuticals Inc

Sector

Healthcare (1106)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(847) 787-7361

Address

21925 W. FIELD PARKWAY, DEER PARK, IL

Employee

Twitter

Next Earnings Date

2026-05-12

Latest SEC Filings

ETON's Discussions on Twitter

Compare ETON vs TAK, ZTS, TEVA, HLN, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ETON Eton Pharmaceuticals Inc	30.38	825.17M	79.95M	-4.60M	10.19M	-0.1787
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-23-25	Reiterated	H.C. Wainwright	Buy
Jan-10-25	Initiated	B. Riley Securities	Buy
Jan-06-25	Reiterated	H.C. Wainwright	Buy
Sep-04-24	Resumed	H.C. Wainwright	Buy
May-06-24	Initiated	Craig Hallum	Buy
Oct-14-21	Resumed	B. Riley Securities	Buy
Jan-04-21	Reiterated	H.C. Wainwright	Buy
Sep-20-19	Initiated	B. Riley FBR	Buy
Jun-10-19	Initiated	H.C. Wainwright	Buy

View All

Eton Pharmaceuticals Inc Stock (ETON) Latest News

01:34 AM

Eton Pharmaceuticals (ETON) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

01:34 AM

08:59 AM

Eton Scales New Highs On Sustained Growth Momentum - RTTNews

08:59 AM

May 04, 2026

Eton Pharmaceuticals (ETON) surges 19.8%: Is this an indication of further gains? - MSN

May 04, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times

May 04, 2026

Eton Pharmaceuticals sets May 14 earnings report, webcast at 4:30 p.m. ET - Stock Titan

May 04, 2026

Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains? - Yahoo Finance

May 04, 2026

May 03, 2026

How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON) - Yahoo Finance

May 03, 2026

May 02, 2026

Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol - Moomoo

May 02, 2026

Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 12-Month HighTime to Buy? - MarketBeat

May 02, 2026

May 01, 2026

Eton Pharmaceuticals (NASDAQ:ETON) Trading 13.3% HigherWhat's Next? - MarketBeat

May 01, 2026

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution - TipRanks

May 01, 2026

Eton Pharmaceuticals relaunches Hemangeol with specialty pharmacy By Investing.com - Investing.com Australia

May 01, 2026